Riting Liu

Title: Riting Liu: Innovator in HPV Research

Introduction

Riting Liu is a notable inventor based in Guangzhou, China. He has made significant contributions to the field of medical research, particularly in the study of human papilloma virus (HPV). His work focuses on developing innovative solutions to combat HPV-related health issues.

Latest Patents

Riting Liu holds a patent for a fine epitope peptide capable of inducing cross-reactive antibodies among homologous proteins in the human papilloma virus E6 protein. This invention relates to the minimal motif of an epitope on the E6 protein from HPV. The minimal motif of the epitope induces a monoclonal antibody that exhibits cross-reactivity with several homologous proteins of HPVs. Liu and his team were the first to identify a fine antigenic epitope that conservatively exists on the E6 proteins of high-risk HPV types 16, 33, 52, and 58. Consequently, the peptides comprising this epitope can be utilized to prepare immunogens or serological detection antigens against HPV E6 proteins, or to create specific universal antibodies for various high-risk and carcinogenic HPVs. He has 1 patent to his name.

Career Highlights

Throughout his career, Riting Liu has worked with various organizations, including Guangdong Nanwan Pharmaceutical Technology Co. Ltd. His expertise in the field has allowed him to contribute to advancements in HPV research and treatment.

Collaborations

Riting Liu has collaborated with Wanxiang Xu, further enhancing the impact of his research and innovations in the medical field.

Conclusion

Riting Liu's contributions to HPV research through his innovative patent demonstrate his commitment to advancing medical science. His work has the potential to significantly impact the detection and treatment of HPV-related diseases.